Literature DB >> 19074504

Human stem cell factor (SCF) is a heparin-binding cytokine.

Satoko Kishimoto1, Shingo Nakamura, Hidemi Hattori, Shin-Ichiro Nakamura, Fumie Oonuma, Yasuhiro Kanatani, Yoshihiro Tanaka, Yasutaka Mori, Yasuji Harada, Masahiro Tagawa, Masayuki Ishihara.   

Abstract

Binding affinities of chemically modified heparins for human stem cell factor (SCF) were examined using fragmin/protamine microparticles (F/P MPs) and an enzyme-linked immunosorbent assay (ELISA). The binding of SCF to F/P MP-coated plates was inhibited with high concentrations of heparin and fragmin, but not others. The binding of SCF was also inhibited with 0.55 M or higher concentrations of NaCl in the medium. These results suggested that a high content of all three sulfate groups in repeating disaccharide units is required for interaction with SCF. Furthermore, pre-immobilized SCF on F/P MP-coated plates significantly stimulated proliferation of a human erythroleukemia cell line.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19074504     DOI: 10.1093/jb/mvn169

Source DB:  PubMed          Journal:  J Biochem        ISSN: 0021-924X            Impact factor:   3.387


  10 in total

1.  Sustained release of stem cell factor in a double network hydrogel for ex vivo culture of cord blood-derived CD34+ cells.

Authors:  Yuanhao Zhang; Xiuwei Pan; Zhen Shi; Haibo Cai; Yun Gao; Weian Zhang
Journal:  Cell Prolif       Date:  2017-11-15       Impact factor: 6.831

Review 2.  Fractones: extracellular matrix niche controlling stem cell fate and growth factor activity in the brain in health and disease.

Authors:  Frederic Mercier
Journal:  Cell Mol Life Sci       Date:  2016-07-30       Impact factor: 9.261

3.  Stem cell factor is essential for preserving NOD/SCID reconstitution capacity of ex vivo expanded cord blood CD34(+) cells.

Authors:  Zheng Du; Ziyan Wang; Weiwei Zhang; Haibo Cai; Wen-Song Tan
Journal:  Cell Prolif       Date:  2015-04-21       Impact factor: 6.831

4.  Natural killer cell differentiation from hematopoietic stem cells: a comparative analysis of heparin- and stromal cell-supported methods.

Authors:  Steven A Dezell; Yong-Oon Ahn; Jan Spanholtz; Hongbo Wang; Matthew Weeres; Scott Jackson; Sarah Cooley; Harry Dolstra; Jeffrey S Miller; Michael R Verneris
Journal:  Biol Blood Marrow Transplant       Date:  2011-12-07       Impact factor: 5.742

5.  Preparation and characterization of low-molecular-weight heparin/protamine nanoparticles (LMW-H/P NPs) as FGF-2 carrier.

Authors:  Yasutaka Mori; Shingo Nakamura; Satoko Kishimoto; Mitsuyuki Kawakami; Satoshi Suzuki; Takemi Matsui; Masayuki Ishihara
Journal:  Int J Nanomedicine       Date:  2010-04-07

6.  Challenges and Opportunities to Harnessing the (Hematopoietic) Stem Cell Niche.

Authors:  Ji Sun Choi; Brendan A C Harley
Journal:  Curr Stem Cell Rep       Date:  2016-01-29

7.  The use of covalently immobilized stem cell factor to selectively affect hematopoietic stem cell activity within a gelatin hydrogel.

Authors:  Bhushan P Mahadik; Sara Pedron Haba; Luke J Skertich; Brendan A C Harley
Journal:  Biomaterials       Date:  2015-07-23       Impact factor: 12.479

8.  Fractone-heparan sulphates mediate FGF-2 stimulation of cell proliferation in the adult subventricular zone.

Authors:  V Douet; A Kerever; E Arikawa-Hirasawa; F Mercier
Journal:  Cell Prolif       Date:  2013-04       Impact factor: 6.831

9.  Selective Expansion of CD34+ Cells from Mouse Bone Marrow Cultured on LH/P MP-Coated Plates with Adequate Cytokines.

Authors:  Satoko Kishimoto; Masayuki Ishihara; Yasuhiro Kanatani; Masaki Nambu; Megumi Takikawa; Yuki Sumi; Shingo Nakamura; Yasutaka Mori; Hidemi Hattori; Yoshihiro Tanaka; Toshinori Sato
Journal:  J Tissue Eng       Date:  2011-10-30       Impact factor: 7.813

Review 10.  Heparinoid Complex-Based Heparin-Binding Cytokines and Cell Delivery Carriers.

Authors:  Masayuki Ishihara; Shingo Nakamura; Yoko Sato; Tomohiro Takayama; Koichi Fukuda; Masanori Fujita; Kaoru Murakami; Hidetaka Yokoe
Journal:  Molecules       Date:  2019-12-17       Impact factor: 4.411

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.